Leveraging its portfolio of patented biomarkers and clinical algorithms, Predictive Biosciences is a leader in developing highly accurate, noninvasive diagnostic products for informed cancer management™, resulting in actionable information for personalized diagnostic follow-up and more effective utilization of gold-standard diagnostic interventions.